Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials

OBJECTIVE: To assess the efficacy and safety of dual sodium glucose cotransporter (SGLT) 1/2 inhibitor sotagliflozin in type 1 diabetes mellitus. DESIGN: Meta-analysis of randomised controlled trials. DATA SOURCES: Medline; Cochrane Library; Embase; international meeting abstracts; international and...

Descripción completa

Detalles Bibliográficos
Autores principales: Musso, Giovanni, Gambino, Roberto, Cassader, Maurizio, Paschetta, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454301/
https://www.ncbi.nlm.nih.gov/pubmed/30967375
http://dx.doi.org/10.1136/bmj.l1328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454301/
https://www.ncbi.nlm.nih.gov/pubmed/30967375
http://dx.doi.org/10.1136/bmj.l1328

Ejemplares similares